Alnylam Pharmaceuticals
ALNY
#586
Rank
A$52.83 B
Marketcap
$409.67
Share price
-1.45%
Change (1 day)
59.60%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company